• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heart failure: Aldosterone antagonism for HFpEF.

作者信息

Borlaug Barry A

出版信息

Nat Rev Cardiol. 2013 May;10(5):244-6. doi: 10.1038/nrcardio.2013.51. Epub 2013 Apr 2.

DOI:10.1038/nrcardio.2013.51
PMID:23546445
Abstract
摘要

相似文献

1
Heart failure: Aldosterone antagonism for HFpEF.
Nat Rev Cardiol. 2013 May;10(5):244-6. doi: 10.1038/nrcardio.2013.51. Epub 2013 Apr 2.
2
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.螺内酯对射血分数保留的心力衰竭患者舒张功能和运动能力的影响：Aldo-DHF 随机对照试验。
JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
3
[Spironolactone not effective in diastolic heart failure].[螺内酯对舒张性心力衰竭无效]
Ned Tijdschr Geneeskd. 2014;158:A7805.
4
Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).“醛固酮受体阻断在舒张性心力衰竭中的作用”试验的原理和设计：一项双盲、随机、安慰剂对照、平行分组研究，旨在确定螺内酯对有症状的舒张性心力衰竭（Aldo-DHF）患者运动能力和舒张功能的影响。
Eur J Heart Fail. 2010 Aug;12(8):874-82. doi: 10.1093/eurjhf/hfq087. Epub 2010 Jun 10.
5
Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
JAMA. 2013 Jul 10;310(2):204-5. doi: 10.1001/jama.2013.7973.
6
Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
JAMA. 2013 Jul 10;310(2):205. doi: 10.1001/jama.2013.7967.
7
Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
JAMA. 2013 Jul 10;310(2):204. doi: 10.1001/jama.2013.7970.
8
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--reply.射血分数保留的心力衰竭患者的醛固酮抑制——回复
JAMA. 2013 Jul 10;310(2):205-7. doi: 10.1001/jama.2013.7976.
9
Blocking aldosterone in heart failure.心力衰竭中醛固酮的阻断
Ther Adv Cardiovasc Dis. 2009 Oct;3(5):379-85. doi: 10.1177/1753944709341300. Epub 2009 Aug 6.
10
Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.醛固酮受体拮抗剂可诱导舒张性心力衰竭患者发生有益的心脏重塑。
Rev Invest Clin. 2007 Mar-Apr;59(2):103-7.

引用本文的文献

1
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂用于射血分数保留的慢性心力衰竭。
Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3.
2
Mineralocorticoid receptor blockade improves pulmonary hypertension and right ventricular function in bronchopulmonary dysplasia: a case report.盐皮质激素受体阻断改善支气管肺发育不良中的肺动脉高压和右心室功能：一例报告
Cardiovasc Diagn Ther. 2020 Oct;10(5):1686-1690. doi: 10.21037/cdt.2020.02.05.
3
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

本文引用的文献

1
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.螺内酯对射血分数保留的心力衰竭患者舒张功能和运动能力的影响：Aldo-DHF 随机对照试验。
JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
2
Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者运动时心输出量对代谢需求的反应。
Eur J Heart Fail. 2013 Jul;15(7):776-85. doi: 10.1093/eurjhf/hft026. Epub 2013 Feb 20.
3
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.
用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
治疗保留心功能心力衰竭伴醛固酮拮抗剂试验的原理和设计：螺内酯治疗有症状心力衰竭和射血分数保留患者的随机对照研究。
Am Heart J. 2011 Dec;162(6):966-972.e10. doi: 10.1016/j.ahj.2011.09.007. Epub 2011 Nov 8.
4
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.射血分数保留的心力衰竭：病理生理学、诊断和治疗。
Eur Heart J. 2011 Mar;32(6):670-9. doi: 10.1093/eurheartj/ehq426. Epub 2010 Dec 7.
5
Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的全球心血管储备功能障碍。
J Am Coll Cardiol. 2010 Sep 7;56(11):845-54. doi: 10.1016/j.jacc.2010.03.077.
6
Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.心力衰竭中通气效率的决定因素：右心室功能和肺血管张力的作用。
Circ Heart Fail. 2008 Nov;1(4):227-33. doi: 10.1161/CIRCHEARTFAILURE.108.785501.
7
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.血管紧张素受体阻滞剂和降压药物对高血压合并舒张功能障碍患者舒张功能的影响：一项随机试验。
Lancet. 2007 Jun 23;369(9579):2079-87. doi: 10.1016/S0140-6736(07)60980-5.
8
Trends in prevalence and outcome of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的患病率及预后趋势
N Engl J Med. 2006 Jul 20;355(3):251-9. doi: 10.1056/NEJMoa052256.
9
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.醛固酮拮抗作用对舒张性心力衰竭高血压患者心肌功能障碍的影响。
Circulation. 2004 Aug 3;110(5):558-65. doi: 10.1161/01.CIR.0000138680.89536.A9. Epub 2004 Jul 26.
10
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.依普利酮、依那普利及依普利酮/依那普利对原发性高血压合并左心室肥厚患者的影响：4E-左心室肥厚研究
Circulation. 2003 Oct 14;108(15):1831-8. doi: 10.1161/01.CIR.0000091405.00772.6E. Epub 2003 Sep 29.